Fertilizers · Founded 1982 · www.kcfl.co.in · BSE 507794 · NSE KHAITAN CHEM · ISIN INE745B01028
No Notes Added Yet
Business
Khaitan Chemicals & Fertilizers Ltd. (KHAICHEM) is an Indian company primarily engaged in the manufacturing and selling of fertilizers and chemicals. Its core business involves the production of Single Super Phosphate (SSP) fertilizer, a phosphatic fertilizer widely used in Indian agriculture, and various industrial chemicals, notably Sulphuric Acid. The company generates revenue by selling these manufactured products to farmers (via distributors/dealers) and industrial clients.
Revenue Mix
While specific revenue percentages are not provided, KHAICHEM's primary operational segments include:
Fertilizers: Focuses on the production and sale of Single Super Phosphate (SSP) and potentially NPK complex fertilizers. This segment caters directly to the agricultural sector.
Chemicals: Manufactures industrial chemicals such as Sulphuric Acid and Oleum, which serve various industrial applications beyond agriculture.
The fertilizer segment typically forms a significant portion of its revenue due to the nature of its business.
Industry
KHAICHEM operates within the Indian fertilizer industry, which is characterized by heavy government regulation, subsidies, and dependence on monsoon patterns. The SSP segment, where KHAICHEM is a player, is competitive and fragmented, with numerous regional manufacturers. The company's positioning is likely that of a mid-tier regional manufacturer, focusing on specific geographical markets in India, competing with both larger integrated players and other regional SSP producers. The industry faces challenges from raw material price volatility and government policy changes.
MOAT
The fertilizer industry, particularly the SSP segment, is largely commodity-driven, making strong moats difficult to establish. KHAICHEM's potential competitive advantages (moats) are likely operational rather than structural:
Regional Scale & Distribution: An established manufacturing presence and a localized distribution network in its operating regions can offer some cost advantages in logistics and market penetration.
Backward Integration: The ability to produce Sulphuric Acid, a key raw material for SSP, can provide some cost stability and supply chain reliability compared to companies entirely dependent on external sourcing.
Brand Recognition (Regional): Over time, a consistent quality product can build a degree of trust and preference among farmers in its target areas, though this is often limited by the commodity nature of the product.
Growth Drivers
Agricultural Growth & Food Security: Increasing demand for food in India drives the need for higher agricultural output, boosting fertilizer consumption.
Government Support for Agriculture: Continued government policies, including fertilizer subsidies and schemes to support farmers, can directly stimulate demand for products like SSP.
Favorable Monsoon: Good monsoons lead to healthy crop cycles and increased farm income, which positively impacts fertilizer sales.
Product & Geographic Expansion: Potential for growth through diversification into other types of fertilizers or chemicals, or expanding its market presence into new regions.
Capacity Utilization & Expansion: Optimizing existing plant utilization and strategic capacity expansions can drive higher sales volumes.
Risks
Government Policy & Regulatory Risk: The Indian fertilizer industry is heavily subsidized and regulated. Changes in subsidy policies, pricing controls, or import duties can significantly impact profitability.
Raw Material Price Volatility: The prices of key raw materials like rock phosphate and sulphur are international commodities, subject to global supply-demand dynamics and currency fluctuations, which can impact production costs and margins.
Monsoon Dependence: A significant portion of India's agriculture is rain-fed, making fertilizer demand highly susceptible to the performance of the monsoon. Poor monsoons can lead to reduced sales.
Competition: The market is competitive with numerous domestic and international players, leading to pricing pressures.
Subsidy Delays: Delays in the disbursement of fertilizer subsidies by the government can strain the company's working capital and liquidity.
Environmental Regulations: Increasingly stringent environmental norms could lead to higher compliance costs and operational challenges.
Management & Ownership
Khaitan Chemicals & Fertilizers Ltd. is typically considered a promoter-driven company, common among Indian enterprises. The promoters (founding family or group) usually hold a significant equity stake, indicating a long-term interest in the company's strategic direction and growth. The management team likely comprises a mix of promoter representatives and professional executives. The ownership structure generally reflects a strong promoter control, which can lead to focused long-term vision but also potential governance considerations.
Outlook
KHAICHEM operates in an essential but often challenging sector. The outlook for the company is sensitive to several external factors. On the positive side, sustained government support for agriculture, stable raw material prices, and favorable monsoon seasons could lead to consistent demand for its fertilizers and chemicals, ensuring stable operational performance and profitability. Its regional presence and potential for backward integration offer some resilience. However, the company faces significant risks from unpredictable changes in government subsidy policies, high volatility in raw material prices, the inherent dependence on agricultural cycles (monsoon), and intense competition. Delays in subsidy payments remain a perennial concern that can impact financial liquidity. Its performance will largely hinge on its ability to manage these external variables and maintain operational efficiency within a highly regulated and commodity-driven environment.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 51 | 130 | 231 | 199 | 161 | 234 | 309 | 266 | 193 | 221 |
| Other Income | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Total Income | 51 | 130 | 231 | 199 | 161 | 234 | 309 | 266 | 194 | 222 |
| Total Expenditure | 78 | 137 | 222 | 188 | 150 | 203 | 278 | 233 | 175 | 197 |
| Operating Profit | -28 | -7 | 9 | 11 | 11 | 32 | 31 | 33 | 18 | 24 |
| Interest | 9 | 7 | 8 | 7 | 7 | 8 | 8 | 9 | 7 | 8 |
| Depreciation | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 3 | 2 | 3 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -39 | -17 | -2 | 1 | 1 | 21 | 22 | 21 | 8 | 13 |
| Provision for Tax | -2 | 0 | 1 | -12 | -8 | -0 | 0 | 0 | 3 | 2 |
| Profit After Tax | -37 | -17 | -3 | 13 | 9 | 21 | 21 | 20 | 5 | 11 |
| Adjustments | -0 | -0 | 0 | 0 | -0 | 0 | 0 | 0 | -4 | 0 |
| Profit After Adjustments | -37 | -17 | -3 | 13 | 9 | 21 | 21 | 20 | 1 | 11 |
| Adjusted Earnings Per Share | -3.9 | -1.7 | -0.3 | 1.3 | 0.9 | 2.2 | 2.2 | 2.1 | 0.6 | 1.1 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 392 | 359 | 353 | 373 | 437 | 481 | 824 | 888 | 536 | 720 | 1002 | 989 |
| Other Income | 2 | 3 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 2 | 2 |
| Total Income | 394 | 362 | 355 | 373 | 439 | 481 | 825 | 889 | 537 | 721 | 1003 | 991 |
| Total Expenditure | 352 | 320 | 317 | 330 | 391 | 419 | 702 | 810 | 566 | 697 | 889 | 883 |
| Operating Profit | 42 | 42 | 38 | 44 | 48 | 62 | 123 | 80 | -29 | 24 | 115 | 106 |
| Interest | 30 | 31 | 26 | 22 | 18 | 14 | 13 | 20 | 32 | 30 | 33 | 32 |
| Depreciation | 9 | 8 | 9 | 9 | 9 | 7 | 7 | 9 | 12 | 11 | 10 | 10 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 3 | 2 | 2 | 13 | 22 | 42 | 103 | 51 | -72 | -16 | 72 | 64 |
| Provision for Tax | 2 | 0 | 1 | 5 | 6 | 15 | 23 | 14 | -1 | -18 | 3 | 5 |
| Profit After Tax | 2 | 2 | 2 | 8 | 15 | 27 | 80 | 37 | -70 | 1 | 69 | 57 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | -2 | -1 | 5 | 0 | 0 | -4 | -4 |
| Profit After Adjustments | 2 | 2 | 2 | 8 | 15 | 25 | 79 | 42 | -70 | 1 | 65 | 53 |
| Adjusted Earnings Per Share | 0.2 | 0.2 | 0.2 | 0.8 | 1.6 | 2.8 | 8.3 | 3.9 | -7.3 | 0.1 | 7.1 | 6 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 39% | 4% | 16% | 10% |
| Operating Profit CAGR | 379% | 13% | 13% | 11% |
| PAT CAGR | 6800% | 23% | 21% | 42% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -62% | -11% | -6% | 9% |
| ROE Average | 27% | 0% | 10% | 8% |
| ROCE Average | 19% | 4% | 13% | 13% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 127 | 129 | 130 | 138 | 153 | 174 | 252 | 294 | 220 | 223 | 291 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 52 | 49 | 42 | 31 | 19 | 19 | 7 | 24 | 17 | 31 | 24 |
| Other Non-Current Liabilities | 5 | 5 | 5 | 8 | 12 | 17 | 18 | 17 | 16 | -1 | 1 |
| Total Current Liabilities | 216 | 254 | 213 | 176 | 206 | 144 | 293 | 368 | 370 | 359 | 363 |
| Total Liabilities | 400 | 438 | 391 | 353 | 391 | 354 | 571 | 707 | 623 | 612 | 678 |
| Fixed Assets | 118 | 118 | 114 | 108 | 102 | 100 | 102 | 129 | 132 | 127 | 118 |
| Other Non-Current Assets | 5 | 8 | 6 | 6 | 6 | 6 | 23 | 17 | 10 | 10 | 19 |
| Total Current Assets | 277 | 312 | 271 | 240 | 282 | 249 | 440 | 558 | 481 | 475 | 536 |
| Total Assets | 400 | 438 | 391 | 353 | 391 | 354 | 571 | 707 | 623 | 612 | 678 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 47 | 0 | 0 | 0 |
| Cash Flow from Operating Activities | 26 | 32 | 64 | 92 | 16 | 84 | 27 | -88 | -55 | 44 | 44 |
| Cash Flow from Investing Activities | -2 | -9 | 0 | -4 | 1 | -6 | -20 | -22 | 2 | -17 | -4 |
| Cash Flow from Financing Activities | -24 | -23 | -65 | -88 | -17 | -79 | 40 | 63 | 53 | -27 | -40 |
| Net Cash Inflow / Outflow | -1 | -0 | -0 | 0 | 0 | -0 | 47 | -47 | -0 | 0 | -0 |
| Closing Cash & Cash Equivalent | 1 | 0 | 0 | 0 | 0 | 0 | 47 | 0 | 0 | 0 | 0 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 0.17 | 0.17 | 0.17 | 0.81 | 1.55 | 2.78 | 8.27 | 3.85 | -7.27 | 0.14 | 7.09 |
| CEPS(Rs) | 1.06 | 1.02 | 1.07 | 1.72 | 2.43 | 3.46 | 9.02 | 4.79 | -6.08 | 1.24 | 8.11 |
| DPS(Rs) | 0.05 | 0.05 | 0.05 | 0.05 | 0.2 | 0.25 | 0.3 | 0.3 | 0 | 0 | 0.05 |
| Book NAV/Share(Rs) | 13.12 | 13.31 | 13.44 | 14.24 | 15.78 | 17.96 | 26.01 | 30.29 | 22.73 | 22.96 | 29.97 |
| Core EBITDA Margin(%) | 10.07 | 10.49 | 10.18 | 11.49 | 10.57 | 12.77 | 14.77 | 8.82 | -5.61 | 3.21 | 11.28 |
| EBIT Margin(%) | 8.32 | 9.14 | 8.13 | 9.34 | 9.14 | 11.51 | 14.03 | 7.97 | -7.47 | 1.85 | 10.45 |
| Pre Tax Margin(%) | 0.84 | 0.58 | 0.68 | 3.37 | 4.93 | 8.69 | 12.49 | 5.75 | -13.41 | -2.29 | 7.16 |
| PAT Margin (%) | 0.42 | 0.45 | 0.46 | 2.12 | 3.45 | 5.6 | 9.73 | 4.21 | -13.15 | 0.19 | 6.86 |
| Cash Profit Margin (%) | 2.59 | 2.71 | 2.92 | 4.47 | 5.4 | 6.97 | 10.62 | 5.23 | -11.01 | 1.67 | 7.85 |
| ROA(%) | 0.42 | 0.4 | 0.4 | 2.12 | 4.06 | 7.23 | 17.33 | 5.85 | -10.6 | 0.23 | 10.67 |
| ROE(%) | 1.31 | 1.29 | 1.27 | 5.88 | 10.36 | 16.47 | 37.6 | 13.68 | -27.41 | 0.63 | 26.79 |
| ROCE(%) | 9.32 | 9.16 | 8.24 | 11.47 | 14.09 | 20.33 | 36.09 | 15.67 | -7.67 | 2.51 | 18.56 |
| Receivable days | 68.17 | 92.61 | 97.84 | 77.21 | 46.99 | 36.87 | 18.09 | 21.19 | 38.84 | 30.73 | 24.54 |
| Inventory Days | 91.16 | 83.12 | 90.33 | 80.22 | 84.25 | 85.43 | 71.21 | 94.84 | 182.19 | 126.58 | 80.19 |
| Payable days | 37.79 | 56.61 | 66.36 | 73.96 | 72.84 | 68.75 | 55.22 | 68.24 | 76.97 | 33.85 | 27.67 |
| PER(x) | 46.84 | 93.33 | 75.9 | 9.9 | 3.52 | 7.92 | 15.24 | 17.39 | 0 | 320.79 | 6.1 |
| Price/Book(x) | 0.61 | 1.2 | 0.96 | 0.57 | 0.35 | 1.22 | 4.84 | 2.21 | 2.83 | 2.02 | 1.44 |
| Dividend Yield(%) | 0.63 | 0.31 | 0.39 | 0.62 | 3.65 | 1.14 | 0.24 | 0.45 | 0 | 0 | 0.12 |
| EV/Net Sales(x) | 0.77 | 1.08 | 0.91 | 0.56 | 0.43 | 0.59 | 1.58 | 0.96 | 1.73 | 1.04 | 0.71 |
| EV/Core EBITDA(x) | 7.2 | 9.29 | 8.56 | 4.78 | 3.85 | 4.61 | 10.56 | 10.71 | -32.55 | 31.12 | 6.17 |
| Net Sales Growth(%) | 19.16 | -8.57 | -1.53 | 5.48 | 17.31 | 10 | 71.32 | 7.77 | -39.64 | 34.4 | 39.08 |
| EBIT Growth(%) | 16.16 | 0.62 | -13.37 | 20.68 | 14.76 | 38.53 | 108.83 | -38.82 | -156.62 | 133.34 | 683.97 |
| PAT Growth(%) | -52.72 | 0.05 | -0.93 | 380.9 | 90.96 | 78.68 | 197.52 | -53.4 | -288.69 | 101.98 | 4814.55 |
| EPS Growth(%) | -52.73 | 0.06 | -0.94 | 380.98 | 90.95 | 78.68 | 197.52 | -53.4 | -288.69 | 101.99 | 4812.96 |
| Debt/Equity(x) | 1.82 | 1.85 | 1.55 | 0.99 | 0.91 | 0.45 | 0.54 | 0.75 | 1.4 | 1.41 | 1.04 |
| Current Ratio(x) | 1.28 | 1.23 | 1.27 | 1.36 | 1.37 | 1.73 | 1.5 | 1.51 | 1.3 | 1.32 | 1.48 |
| Quick Ratio(x) | 0.98 | 0.83 | 0.92 | 0.86 | 0.82 | 0.95 | 0.79 | 0.83 | 0.54 | 0.72 | 0.86 |
| Interest Cover(x) | 1.11 | 1.07 | 1.09 | 1.57 | 2.17 | 4.07 | 9.1 | 3.59 | -1.26 | 0.45 | 3.18 |
| Total Debt/Mcap(x) | 2.99 | 1.55 | 1.62 | 1.75 | 2.61 | 0.37 | 0.11 | 0.34 | 0.5 | 0.7 | 0.72 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.99 | 72.52 | 72.52 | 72.52 | 72.55 | 72.58 | 72.65 | 72.65 | 72.65 | 72.65 |
| FII | 0.09 | 0.08 | 0.08 | 0.16 | 0.48 | 0.79 | 0.32 | 0.34 | 0.11 | 0.08 |
| DII | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 24.9 | 27.39 | 27.39 | 27.31 | 26.96 | 26.62 | 27.02 | 27.01 | 27.24 | 27.27 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 7.27 | 7.03 | 7.03 | 7.03 | 7.04 | 7.04 | 7.05 | 7.05 | 7.05 | 7.05 |
| FII | 0.01 | 0.01 | 0.01 | 0.02 | 0.05 | 0.08 | 0.03 | 0.03 | 0.01 | 0.01 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 2.42 | 2.66 | 2.66 | 2.65 | 2.62 | 2.58 | 2.62 | 2.62 | 2.64 | 2.64 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9.7 | 9.7 | 9.7 | 9.7 | 9.7 | 9.7 | 9.7 | 9.7 | 9.7 | 9.7 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +39% | +4% | +16% | +10% |
| Operating Profit CAGR | +379% | +13% | +13% | +11% |
| PAT CAGR | +6800% | +23% | +21% | +42% |
| Share Price CAGR | -62% | -11% | -6% | +9% |
| ROE Average | +27% | 0% | +10% | +8% |
| ROCE Average | +19% | +4% | +13% | +13% |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.99 | 72.52 | 72.52 | 72.52 | 72.55 | 72.58 | 72.65 | 72.65 | 72.65 | 72.65 |
| FII | 0.09 | 0.08 | 0.08 | 0.16 | 0.48 | 0.79 | 0.32 | 0.34 | 0.11 | 0.08 |
| DII | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 24.9 | 27.39 | 27.39 | 27.31 | 26.96 | 26.62 | 27.02 | 27.01 | 27.24 | 27.27 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 7.27 | 7.03 | 7.03 | 7.03 | 7.04 | 7.04 | 7.05 | 7.05 | 7.05 | 7.05 |
| FII | 0.01 | 0.01 | 0.01 | 0.02 | 0.05 | 0.08 | 0.03 | 0.03 | 0.01 | 0.01 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 2.42 | 2.66 | 2.66 | 2.65 | 2.62 | 2.58 | 2.62 | 2.62 | 2.64 | 2.64 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9.7 | 9.7 | 9.7 | 9.7 | 9.7 | 9.7 | 9.7 | 9.7 | 9.7 | 9.7 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.